By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 120.67 |
| Change Today | $ -3.68 |
| % Change | -2.96 % |
| 52 Week High | $128.07 |
| 52 Week Low | $89.14 |
| Volume | 6,712,725 |
| Shares Issued | 1,246.00m |
| Market Cap | $150,355m |
| RiskGrade | 120 |
| Strong Buy | 9 |
| Buy | 13 |
| Neutral | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 16:00 | 1,200,171 @ $120.67 |
| 15:59 | 123 @ $120.65 |
| 15:59 | 200 @ $120.65 |
| 15:59 | 182 @ $120.65 |
| 15:59 | 100 @ $120.65 |
You are here: research